BioCentury
ARTICLE | Clinical News

GI-5005: Completed Phase II enrollment

May 26, 2008 7:00 AM UTC

GlobeImmune completed enrollment of 120 patients with chronic HCV genotype 1 infection in an open-label, international Phase II trial evaluating pegylated interferon plus ribavirin with or without sub...